GLP-1 · Investigational

Retatrutide

Retatrutide is an investigational GLP-1/GIP/glucagon triple-receptor agonist currently in Phase 3 trials. NOT FDA-approved; for research use only.

Compliance note

Retatrutide is non-FDA-approved investigational drug. Disclaimer interstitial REQUIRED before add-to-cart. Lawyer review pending.